EMEA-000332-PIP02-17-M03
Key facts
| Invented name |
Briviact (in Italy: Nubriveo)
|
| Active substance |
Brivaracetam
|
| Therapeutic area |
Neurology
|
| Decision number |
P/0003/2022
|
| PIP number |
EMEA-000332-PIP02-17-M03
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
|
| Contact for public enquiries |
UCB Pharma S.A.
Tel. + 353 14632371 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|